Browse All

Current Filters

CLEAR FILTER x

TITLE

TRPM 8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine

Author:Lauring, Brett   Goadsby, Peter   Saikali, Nicolas   Arreglado, Anna   Liu, Jiajun   Vance, Annemarie   Zhang, Harry   Crutchlow, Michael   

Session Name:S37: Headache Clinical Trials  

Topic:Headache  

Program Number:S37.001  

Author Institution:Kallyope, Inc, New York, NY  King Abdullah University of Science and Technology, Saudi Arabia & Clinical Research Facility, King’s College London, UK, Saudi Arabia  Dent Neurologic Institute, Buffalo, NY  Kallyope, Inc, NY  

Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCom Trial

Author:van Eeghen, Agnies   Wilson, Sarah M.L.   Thiele, Elizabeth A.   Roszkowski, Stevie   Dunaway-Bryant, Maria   Wajer, Kasia   Greco, Teresa   Stevens, Joanne   Moore-Ramdin, Lisa   de Vries, Petrus J.   

Session Name:S5: Clinical Epilepsy  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:S5.005  

Author Institution:Amsterdam University Medical Centers  Advisium, ’s Heeren Loo, Amsterdam, Netherlands  McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX  Massachusetts General Hospital, MA  Jazz Pharmaceuticals, Inc., MA  Jazz Pharmaceuticals, Inc., PA  Jazz Pharmaceuticals, UK Ltd., United Kingdom  Jazz Pharmaceuticals, Inc., Italy  Jazz Pharmaceuticals, Inc., Philadelphia, PA  Jazz Pharmaceuticals, UK Ltd., Southampton, United Kingdom  Centre for Autism Research in Africa, University of Cape Town, South Africa  

Tubo-ovarian Abscesses in Women With Multiple Sclerosis Treated With B-cell Depleting Therapy

Author:Hunter, Jessica   Conway, Sarah   

Session Name:P10: Multiple Sclerosis: Adverse Events  

Topic:Multiple Sclerosis  

Program Number:P10.008  

Author Institution:Mass General Brigham, Boston, MA  

Tumefactive Demyelination at Multiple Sclerosis Onset Associates With Less Severe Long-term Disability

Author:Aboseif, Albert   Neyal, Nur   Atkinson, Elizabeth   Tarlton, Caitlin   Schwarz, Christopher   Decker, Paul   Kosel, Matthew   Son, Jiye   Keegan, Mark   Kantarci, Kejal   Kantarci, Orhun   Tobin, W.   Zeydan, Burcu   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:P4.006  

Author Institution:Mayo Clinic, Rochester, MN  Mayo Clinic, MN  Dalhousie University, Halifax, NS, Canada  

Tumefactive Demyelination in NMOSD Presenting as a Thalamic Lesion With Midline Shift

Author:Kiapour, Nazanin   Herrera, Henry   Heidarpour Bardei, Negar   Duran, Melanie   Esfahanizadeh, Abdolreza   Bhise, Vikram   

Session Name:P3: Multiple Sclerosis: NMOSD, MOGAD, and Other Mimickers of MS 1  

Topic:Multiple Sclerosis  

Program Number:P3.010  

Author Institution:JFK-HMH Medical Center, NJ  Rutgers Robert Wood Johnson University Hospital, Waldwick, NJ  Rutgers Robert Wood Johnson University Hospital, middletown, CA  Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ